Skip to content

Glutamic Acid Decarboxylase Antibodies (Anti-GAD65) in Serum

Published: August 9, 2026Updated: August 16, 2026

This test measures the presence of antibodies against glutamic acid decarboxylase (GAD65), a protein involved in insulin production in the pancreas. It helps evaluate potential autoimmune diabetes, such as type 1 diabetes.

Quick summary

["This test may help diagnose or monitor autoimmune conditions affecting the pancreas."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
112068-2
Short code
GAD65 Ab CSF IA-aCnc
Synonyms
GAD65 Ab CSF IA-aCnc
Category
chemistry
Sample
csf
Container
Sterile tube
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
ia
Specimen volume
1-2 mL
Stability
Immediate analysis required, Refrigerated: 1h
Hemolysis max
200
TAT
4–24 hours
Order
routine

Why This Test Might Be Ordered

Your healthcare provider may recommend this test if you have symptoms like unexplained weight loss, frequent thirst, frequent urination, or unexplained fatigue. It may also be used in patients with a family history of type 1 diabetes or other autoimmune diseases.

What to Expect Before the Test

No special preparation is needed for this blood test. You may have a small needle inserted into your arm to draw a blood sample. If you are diabetic or on insulin, let your healthcare provider know before the test.

What the Test Results Mean

Positive results indicate the presence of anti-GAD65 antibodies, which can suggest an autoimmune response targeting pancreatic cells. However, results alone do not diagnose diabetes; they are often used alongside other tests and clinical findings.

Common Conditions Linked to Positive Results

Anti-GAD65 antibodies are strongly associated with type 1 diabetes and other autoimmune conditions affecting the pancreas, such as diabetes-related complications or related syndromes. They may also appear in other autoimmune diseases.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Anti-GAD65 antibodies are a key marker for diagnosing and monitoring autoimmune diabetes. High levels may indicate an increased risk of developing type 1 diabetes, especially in individuals with other autoimmune markers or a family history of the disease. Regular monitoring can help manage symptoms and prevent complications.

Short name

Anti-GAD65 Antibody

Frequently asked questions

What does a positive result mean?
A positive result suggests your body is producing antibodies against GAD65, which is linked to autoimmune processes affecting the pancreas. This may indicate a higher likelihood of type 1 diabetes or related conditions, but further evaluation with other tests and clinical assessment is needed.
Can this test be used to diagnose diabetes?
This test helps identify a potential autoimmune cause for diabetes but is not definitive on its own. It is often used alongside other tests, such as fasting glucose or C-peptide levels, to support a diagnosis.
Are there any side effects from this blood test?
Most people experience only minor discomfort or bruising at the injection site. Rarely, there may be a slight reaction like redness or swelling. If you experience severe pain or other unusual symptoms, contact your healthcare provider.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy